Skip to main content

Advertisement

Table 2 HIV-related characteristics of HIV-infected participants by HBV infection status (N = 2419)

From: Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada

Clinical CharacteristicsHIV
N = 2220
HIV-HBV
Co-Infected
N = 199
p valuea
Baseline HIV viral load (Log10 copies/mL)
  < 4332 (15)30 (15)0.87
 4–51011 (46)94 (47) 
  > 5877 (40)75 (38) 
End of follow-up HIV viral load (Log10 copies/mL)
  < 42104 (95)193 (97)0.38
 4–569 (3)4 (2) 
  > 547 (2)2 (1) 
Baseline CD4 T cell count (cells/mm3)235 (120–360)188 (85–294)0.0002
Baseline CD4 T cell count category (cells/mm3)
  ≤ 199897 (40)105 (53)0.002
 200–349720 (32)60 (30) 
 350–499367 (17)24 (12) 
  > 500236 (11)10 (5) 
Baseline AIDS-Defining Illnessb
  ≥ 1446 (20)55 (28)0.01
 None1774 (80)144 (72) 
Years on ARV therapy5.01 (2.50–8.75)5.97 (3.11–9.94)0.003
HIV Suppressed since FARVDT2040 (92)190 (96)0.07
HIV Rebound (since first VS)481 (24)56 (29)0.07
  1. VS virological suppression, FARVDT first naïve ARV date
  2. aData shown are frequencies and proportions for categorical variables and median and interquartile ranges for continuous variables. p values for continuous variables were calculated using chi-square or Fisher exact tests and for continuous variables were calculated using Wilcoxon’s Rank Sum tests
  3. bAIDS-defining illness present prior to or before first naïve ARV date